Abiomed Inc (Abiomed) is a medical device company that develops, manufactures and markets circulatory support devices. The devices replace or assist the pumping function in a failing heart. The company’s heart support and recovery product portfolio includes Impella heart pumps (catheter-based devices including micro heart pumps, expandable catheter pumps and axial flow pumps) and Breethe system (implantable cardiac and respiratory assist devices). Abiomed also offers online clinical support through Impella Connect, on-call assistance and on-site assistance for health workers in hospitals. The company sells its products through direct sales and distributors in South America, Europe, Asia, and the Middle East. Abiomed is headquartered in Danvers, Massachusetts, the US.

Headquarters United States of America

Address 22 Cherry Hill Dr, Danvers, Massachusetts, 01923-2575


Telephone 1 978 7775410

No of Employees 2,003

Industry Medical Equipment

Ticker Symbol & Exchange ABMD (NASD)

Revenue (2022) $1.0B 21.7% (2022 vs 2021)

EPS XXX

Net Income (2022) XXX -39.5% (2022 vs 2021)

Market Cap* $17.0B

Net Profit Margin (2022) XXX -50.3% (2022 vs 2021)

* As of and is in US$

Access premium data and analytics for Abiomed Inc

50+

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

20+

Medical Marketed Products

A database of medical devices currently for sale around the world. Devices that have been approved by a regulatory authority are included.

13+

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

150+

Install Base

Install Base provides a holistic and a granular view of the IT product/service deployments from leading vendors. Explore IT infrastructure categories, solution and product/service areas deployed by a prospect.

3

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Abiomed Inc’s relevant decision makers and contact details.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Abiomed Inc’s likely spend across technology areas enabling you to understand the digital strategy.

1

Clinical Trials

Determine Abiomed Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

Subscribe to Company Analytics & gain access to premium industry data & analytics Subscribe to Company Analytics & gain access to premium industry data & analytics Start Here

Products and Services

Products Services Brands
Impella 2.5 Catheter Impella Connect- Cloud-based remote monitoring Abiomed
Impella CP heart pump Impella
Impella 5.0 and Impella LD Percutaneous Micro Heart Pumps Impella 2.5
XXX XXX
XXX XXX
XXX XXX
Subscribe to Company Analytics for access to more products & services data Subscribe to Company Analytics for access to more products & services data Learn More

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2022 Contracts/Agreements In November, the company agreed to be acquired by Johnson & Johnson for US$16.6 billion.
2022 Regulatory Approval In September, the company received approvals from the US FDA related to clinical research of Impella heart pumps in acute myocardial infarction cardiogenic shock patients.
2022 Regulatory Approval In January, the company received an approval of Impella 5.5 With SmartAssist in Japan and Hong Kong.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Get Started
Image for loader

Competitor Comparison

Key Parameters Abiomed Inc Abbott Laboratories Medtronic Plc Boston Scientific Corp Terumo Corp
Headquarters United States of America United States of America Ireland United States of America Japan
City Danvers Abbott Park Dublin Marlborough Shibuya-Ku
State/Province Massachusetts Illinois - Massachusetts Tokyo
No. of Employees 2,003 113,000 95,000 41,000 28,294
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Michael R. Minogue Chairman; President; Director; Chief Executive Officer Executive Board 2004 54
Todd A. Trapp Vice President; Chief Financial Officer Senior Management 2018 50
David M. Weber, Ph.D. Chief Operating Officer Senior Management 2007 59
Thorsten Siess, Ph.D. Vice President; Chief Technology Officer Senior Management 2005 -
Charles Simonton, M.D Chief Medical Officer; Vice President Senior Management 2020 -
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Gain more insight into company management & employee structure with Company Analytics Gain more insight into company management & employee structure with Company Analytics Subscribe
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company Analytics

Contact the team or request a demo to find out how our data can drive your business forward

Why are you leaving?